|
GS185131: GO:0044699 single-organism process
|
|
GS135951: HDL QTL 19 (Hdlq19, Published QTL Chr 2)
|
|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS136811: total cholesterol QTL 2 (Tcq2, Published QTL Chr 2)
|
|
GS201949: GO:0044699 single-organism process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS188698: GO:0003012 muscle system process
|
|
GS192041: GO:0043169 cation binding
|
|
GS136888: voluntary alcohol consumption QTL 1 (Vacq1, Published QTL Chr 2)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS84142: alcohol preference locus (Published QTL, Chr 2)
|
|
GS135377: body length QTL 7 (Bdlnq7, Published QTL Chr 2)
|
|
GS136493: proteoglycan induced arthritis 2 (Pgia2, Published QTL Chr 2)
|
|
GS136535: promotion susceptibility QTL 2 (Psl2, Published QTL Chr 2)
|
|
GS35795: Whole Brain Gene expression correlates of CPP- Time (s) spent in saline paired compartment a in Males BXD
|
|
GS205610: GO:0044430 cytoskeletal part
|
|
GS180296: GO:0005509 calcium ion binding
|
|
GS135604: circulating hormone level QTL 13 (Chlq13, Published QTL Chr 2)
|
|
GS84138: METH responses for climbing (Published QTL, Chr 2)
|
|
GS195875: GO:0030049 muscle filament sliding
|
|
GS191106: GO:0044464 cell part
|
|
GS136018: heart failure modifier 5 (Hrtfm5, Published QTL Chr 2)
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS201251: GO:0044424 intracellular part
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS135767: experimental allergic encephalomyelitis susceptibility 8 (Eae8, Published QTL Chr 2)
|
|
GS135502: bladder tumor susceptibility 1 (Bts1, Published QTL Chr 2)
|
|
GS207523: GO:0003779 actin binding
|
|
GS136417: orthodenticle homolog 2 (Drosophila) modifier 2 (Otx2m2, Published QTL Chr 2)
|
|
GS203985: GO:0005865 striated muscle thin filament
|
|
GS84143: alcohol consumption (Published QTL, Chr 2)
|
|
GS129170: prion disease incubation time 2 (Prdt2 Published QTL Chr 2)
|
|
GS208978: GO:0043169 cation binding
|
|
GS180531: GO:0050881 musculoskeletal movement
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS198624: GO:0033275 actin-myosin filament sliding
|
|
GS135378: bone density traits 1 (Bdt1, Published QTL Chr 2)
|
|
GS129138: growth and fatness 3 (Gnf3 Published QTL Chr 2)
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS189443: GO:0044449 contractile fiber part
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS186744: GO:0043226 organelle
|
|
GS206312: GO:0044449 contractile fiber part
|
|
GS129180: spontaneous crescentic glomerulonephritis QTL 3 (Scgq3 Published QTL Chr 2)
|
|
GS182835: GO:0005622 intracellular
|
|
GS135281: "alcohol preference locus 5, male specific" (Alcp5, Published QTL Chr 2)
|
|
GS194613: GO:0008092 cytoskeletal protein binding
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS121161: Arsenic interacting genes (MeSH:D001151) in CTD
|
|
GS189860: GO:0043167 ion binding
|
|
GS202898: GO:0050879 multicellular organismal movement
|
|
GS204054: GO:0044057 regulation of system process
|
|
GS206742: GO:0043167 ion binding
|
|
GS197956: GO:0006941 striated muscle contraction
|
|
GS198670: GO:0090257 regulation of muscle system process
|
|
GS126172: BXL628 interacting genes (MeSH:C487049) in CTD
|
|
GS136192: learning-contextual 10 (Lrnx10, Published QTL Chr 2)
|
|
GS136391: organ weight 1 (Org1, Published QTL Chr 2)
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS187125: GO:0005865 striated muscle thin filament
|
|
GS128575: Ethanol induced LORR Chr# 2
|
|
GS136714: susceptibility to lung cancer 17 (Sluc17, Published QTL Chr 2)
|
|
GS181473: GO:0005488 binding
|
|
GS84139: nicotine sensitivity (Published QTL, Chr 2)
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS208921: GO:0030016 myofibril
|
|
GS135282: "alcohol preference locus 6, female specific" (Alcp6, Published QTL Chr 2)
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|
|
GS136842: telomere length QTL 1 (Tlq1, Published QTL Chr 2)
|
|
GS135311: autoimmune ovarian dysgenesis 4 (Aod4, Published QTL Chr 2)
|
|
GS135903: granulosa cell tumorigenesis 8 (Gct8, Published QTL Chr 2)
|
|
GS135575: cystic fibrosis lung disease 1 (Cfld1, Published QTL Chr 2)
|
|
GS136915: vertebral morphology and mechanical traits 3 (Vmmt3, Published QTL Chr 2)
|
|
GS186066: GO:0050879 multicellular organismal movement
|
|
GS198263: GO:0005488 binding
|
|
GS84136: ethanol induced locomotion (Published QTL, Chr 2)
|
|
GS136449: postnatal body weight growth 11 (Pbwg11, Published QTL Chr 2)
|
|
GS191982: GO:0030016 myofibril
|
|
GS209959: GO:0003009 skeletal muscle contraction
|
|
GS84140: alcohol consumption (Published QTL, Chr 2)
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS193018: GO:0003008 system process
|
|
GS135725: duration of locomotor activity 1 (Dloc1, Published QTL Chr 2)
|
|
GS184447: GO:0044424 intracellular part
|
|
GS205557: GO:0003012 muscle system process
|
|
GS136338: nicotine induced locomotor activity 3 (Nilac3, Published QTL Chr 2)
|
|
GS191983: GO:0030017 sarcomere
|
|
GS34730: Striatum Gene expression correlates of Novel environment rears 30-45 min in the periphery in Females BXD
|
|
GS182469: GO:0043234 protein complex
|
|
GS188751: GO:0044430 cytoskeletal part
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS180164: GO:0008150 biological_process
|
|
GS202942: GO:0006937 regulation of muscle contraction
|
|
GS210709: GO:0070252 actin-mediated cell contraction
|
|
GS197324: GO:0050881 musculoskeletal movement
|
|
GS186108: GO:0006936 muscle contraction
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS136770: spleen weight QTL 6 (Swq6, Published QTL Chr 2)
|
|
GS136951: weight gain in high growth mice 6 (Wg6, Published QTL Chr 2)
|
|
GS84137: high-dose ethanol actions (Published QTL, Chr 2)
|
|
GS181167: GO:0006941 striated muscle contraction
|
|
GS135808: erosive arthritis susceptibility 1 (Erars1, Published QTL Chr 2)
|
|
GS135915: gestational survival modifier locus (Gstml, Published QTL Chr 2)
|
|
GS205123: GO:0030029 actin filament-based process
|
|
GS135515: "body weight, QTL 5" (Bwq5, Published QTL Chr 2)
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS135345: atherosclerotic lesion area 1 (Athla1, Published QTL Chr 2)
|
|
GS189317: GO:0043292 contractile fiber
|
|
GS135927: hepatocarcinogenesis susceptibility 4 (Hcs4, Published QTL Chr 2)
|
|
GS182834: GO:0005623 cell
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS135407: body growth late QTL 2 (Bglq2, Published QTL Chr 2)
|
|
GS207365: GO:0005829 cytosol
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS207161: GO:0006928 cellular component movement
|
|
GS136132: lithogenic gene 12 (Lith12, Published QTL Chr 2)
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|
|
GS208922: GO:0030017 sarcomere
|
|
GS195876: GO:0030048 actin filament-based movement
|
|
GS34735: Striatum Gene expression correlates of Novel environment rears 30-45 min in the periphery in Males BXD
|
|
GS188368: GO:0015629 actin cytoskeleton
|
|
GS201256: GO:0044422 organelle part
|
|
GS201431: GO:0005515 protein binding
|
|
GS135287: alcohol response 2 (Alcrsp2, Published QTL Chr 2)
|
|
GS135984: hematocrit QTL 2 (Hemq2, Published QTL Chr 2)
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS191954: GO:0005856 cytoskeleton
|
|
GS205224: GO:0015629 actin cytoskeleton
|
|
GS199267: GO:0043234 protein complex
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS188252: GO:0005861 troponin complex
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS87306: Table S1: 109 genes are differentially down- (-) or up-(+ ) regulated in the CPu in D1 receptor mutant mice compared to wild-type mice after repeated cocaine administration (Whole Table) [DRG]
provisional
|
|
GS205107: GO:0005861 troponin complex
|
|
GS197076: GO:0005509 calcium ion binding
|
|
GS202941: GO:0006936 muscle contraction
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS213073: Genes with suggestive difference in (PB6F1) vs (B6PF1 + B6 + PWD) comparison
|
|
GS125936: Tunicamycin interacting genes (MeSH:D014415) in CTD
|
|
GS129086: blood glucose level 1 (Bglu1 Published QTL Chr 2)
|
|
GS34653: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in BXD Females
|
|
GS34516: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 30-45 min in the periphery in BXD Males
|
|
GS135373: body length 3 (Bdln3, Published QTL Chr 2)
|
|
GS34662: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in BXD Males
|
|
GS136885: urinary albuminuria 1 (Ua1, Published QTL Chr 2)
|
|
GS136162: leishmaniasis resistance 16 (Lmr16, Published QTL Chr 2)
|
|
GS203594: GO:0043226 organelle
|
|
GS135439: bone mineral density 6 (Bmd6, Published QTL Chr 2)
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS209960: GO:0003008 system process
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS206183: GO:0043292 contractile fiber
|
|
GS193017: GO:0003009 skeletal muscle contraction
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS127166: bisphenol A interacting genes (MeSH:C006780) in CTD
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS135442: bone marrow graft rejection 3 (Bmgr3, Published QTL Chr 2)
|
|
GS136588: renal disease susceptibility (Rends, Published QTL Chr 2)
|